Plain-English translation of NCT07758816 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This research study is designed to better understand Gaucher disease โ a rare genetic condition where the body cannot break down certain fats โ in patients who are already receiving standard treatment. Researchers want to learn why some people continue to have problems even while on therapy, particularly focusing on lung and bone complications, and on a link between Gaucher disease and Parkinson's disease symptoms. By carefully tracking your health over time and studying samples from your cells, the research team hopes to identify new ways to help patients whose disease doesn't fully respond to current treatments.
Even with the best available treatments, some people with Gaucher disease continue to experience serious complications affecting their lungs, bones, and nervous system. This study exists to understand why this happens and to find clues that could lead to better treatment options for patients whose disease remains difficult to control.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will continue receiving your regular Gaucher disease treatment while researchers track how you are doing over time. Depending on which group you are in, you may have visits where doctors examine you, run blood tests, take imaging scans (like chest X-rays), and ask detailed questions about your symptoms and health. Some participants may also provide small cell samples to help researchers understand the disease at a deeper level. The study is observational, meaning researchers are watching and learning from what happens as you receive your normal care โ they are not testing a brand new medication.
AI-generated summary from trial data ยท Sep 24, 2026 ยท Not medical advice
United States
Yale University
Collaborators
Sanofi-Yale External Research Collaboration
Enrollment target
~30 participants
Started
May 2026
Primary completion
September 2030
Age range
3 Months โ 75 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Pramod Yang, BS, CCRG
Yale University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.